EpiBiologics Stock

Enables removal of disease-driving extracellular and membrane proteins via antibodies for tissue-selective therapeutic effects.

Buy

Buy EpiBiologics shares

Sign up to view historical trading trends and place an offer.

Sell

Sell EpiBiologics shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Overview

EpiBiologics designs antibody-based therapies that target proteins found on the cell surface or outside cells for degradation, aiming to eliminate disease-causing factors that current intracellular approaches can’t reach. It uses a proprietary platform (EpiTAC) to map and engage cell-surface receptors in tissue-selective ways, enabling precise removal of problematic membrane or extracellular proteins while sparing healthy tissue.

Sector

Healthcare & Life Sciences

Founded

2022

Headquarters

San Mateo, CA

Buy

Buy EpiBiologics shares

Sign up to view historical trading trends and place an offer.

Sell

Sell EpiBiologics shares

Understand share pricing, list anonymously, and benefit from transparent fees.

EpiBiologics Management Team

EpiBiologics people and management

  • CEO, President, Board Member
    Ann Lee-Karlon
  • CFO
    Aaron Mishel
  • COO
    Craig Lichtenstein
  • Board Member
    Alexandra Cantley
  • Board Member
    James Wells
  • Board Member
    Jason Coloma
  • Board Member
    Mitchell Mutz
  • Board Member
    Samuel Bjork
  • Board Member
    Seiji Miyahara
  • Chief Business Officer
    Jennifer Cygan
  • Chief Medical Officer
    Eric Humke
  • Chief Scientific Officer
    Shyra Gardai

EpiBiologics Valuations & Financials

Gain Insights Into EpiBiologics Stock Valuation & Share Prices

View real-time NPM data on EpiBiologics stock including daily EpiBiologics stock price estimates, valuation history, and historical share price information. Access EpiBiologics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track EpiBiologics pricing across six independent market signals. Looking for private company due diligence data sources on EpiBiologics? Get in touch to learn more.

Similar Companies

Explore companies

like EpiBiologics

  • Pharmazz

    Healthcare & Life Sciences

    Develops therapeutics that restore critical care functions through innovative endothelin‑based drug mechanisms.

  • MedTrainer

    Healthcare & Life Sciences

    Healthcare compliance platform streamlines credentialing, training and regulatory management through automated tools and integrated solutions.

  • Carallel

    Healthcare & Life Sciences

    Develops a support platform that guides caregivers with resources, expert assistance, and tools for managing care responsibilities.

  • Optain Health

    Healthcare & Life Sciences

    Utilizes AI-enhanced retinal imaging to provide rapid, non-invasive screening for ocular and systemic diseases, facilitating early detection and improved patient outcomes.

  • Edifice Health

    Healthcare & Life Sciences

    Delivering an AI-driven inflammation age metric paired with personalized interventions to proactively strengthen immune and systemic health.

  • NanoImaging

    Healthcare & Life Sciences

    Delivers high‑resolution imaging for structural insights via integrated cryo‑EM and nanoparticle characterization services.

  • Cadence

    Healthcare & Life Sciences

    Remote patient monitoring platform enables healthcare providers to track vitals and manage chronic conditions in real-time.

  • Enzo Health

    Healthcare & Life Sciences

    Provides an AI-powered platform purpose-built for home health agencies, unifying front office, clinical, and back-office operations in a single system.

  • Professional Credentials Exchange

    Healthcare & Life Sciences

    Offers a platform that securely manages and exchanges verified credentials while streamlining compliance and reducing redundant administrative work.

FAQ

Questions?

We have answers

Buy EpiBiologics Stock

EpiBiologics stock does not trade on public stock exchanges. EpiBiologics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in EpiBiologics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell EpiBiologics Stock

EpiBiologics Stock does not trade on public stock exchanges. In order to sell EpiBiologics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

 

EpiBiologics Stock Price

EpiBiologics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view EpiBiologics share price and other valuable private market data.

Read more about secondary market private company stock prices:

EpiBiologics Stock Ticker Symbol

There is no ticker symbol for EpiBiologics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell EpiBiologics Stock

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell EpiBiologics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

 

Criteria to Buy or Invest in EpiBiologics Stock

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in EpiBiologics stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

EpiBiologics Stock Settlement

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

EpiBiologics IPO

EpiBiologics is a private company and has not had an IPO. There is currently no EpiBiologics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to EpiBiologics IPO.

Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.